Other OTC Pharmaceuticals - Belgium

Belgium

Highlights

In Belgium, the revenue generated in the market Other OTC Pharmaceuticals amounted to US$281.30m in 2024.
It is projected that the market will experience an annual growth rate of 0.90% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue in this market, reaching US$7.17bn in 2024.
In terms of per person revenues, in Belgium generates US$24.01 in 2024.
Belgium's Other OTC Pharmaceuticals market is witnessing a surge in demand for homeopathic remedies and natural supplements.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in Belgium is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences: Belgian consumers are increasingly opting for over-the-counter (OTC) pharmaceuticals for the treatment of minor ailments and self-care. This shift in consumer behavior can be attributed to several factors, including convenience, cost-effectiveness, and the desire for more control over one's healthcare. Additionally, the growing awareness of the potential side effects of prescription medications has led many consumers to seek alternative options for managing their health.

Trends in the market: One of the key trends in the Other OTC Pharmaceuticals market in Belgium is the rising demand for natural and herbal remedies. Consumers are becoming more conscious of the potential benefits of natural ingredients and are seeking products that align with their preference for organic and sustainable options. This trend is driven by a desire for holistic health solutions and a growing interest in traditional medicine. As a result, manufacturers are increasingly focusing on developing and promoting OTC products that contain natural ingredients and have fewer side effects.Another trend in the market is the increasing availability and popularity of online pharmacies. Belgian consumers are embracing the convenience and accessibility of online shopping, including purchasing OTC pharmaceuticals. Online pharmacies offer a wide range of products, competitive prices, and home delivery, making it easier for consumers to access the OTC medications they need. This trend is expected to continue as more consumers become comfortable with online purchasing and seek to streamline their healthcare routines.

Local special circumstances: Belgium has a well-developed healthcare system, with a strong emphasis on patient-centered care. The country's healthcare infrastructure, including pharmacies and healthcare professionals, plays a crucial role in promoting the use of OTC pharmaceuticals. Pharmacists in Belgium are highly trained and well-positioned to provide advice and guidance to consumers on the appropriate use of OTC medications. This trust and accessibility contribute to the growing popularity of OTC pharmaceuticals in the country.

Underlying macroeconomic factors: The growth of the Other OTC Pharmaceuticals market in Belgium is also influenced by macroeconomic factors such as population demographics and healthcare expenditure. Belgium has an aging population, which is driving the demand for OTC medications used for chronic conditions and age-related ailments. Additionally, the government's focus on cost containment in healthcare expenditure has led to increased reliance on self-care and OTC products, as they are generally more affordable than prescription medications.In conclusion, the Other OTC Pharmaceuticals market in Belgium is witnessing growth due to changing customer preferences, emerging trends, and local special circumstances. Consumers are increasingly opting for OTC pharmaceuticals for minor ailments and self-care, with a growing preference for natural and herbal remedies. The availability of online pharmacies is also contributing to the market's expansion. Belgium's well-developed healthcare system and aging population further support the demand for OTC medications.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.